期刊文献+

肠道病毒71型VP1蛋白原核表达及初步鉴定

Expression of VP1 protein of enterovirus 71 in E. coli and verification of the expressive product.
下载PDF
导出
摘要 目的采用分子克隆技术,构建肠道病毒71型(EV71)VP1全长基因大肠杆菌原核系统表达载体,诱导重组VP1融合蛋白表达。方法自EV71感染患者血清中提取病毒总RNA,进行一步法RT-PCR,扩增编码VP1蛋白的全长基因片段(891 bp),以pET32(a)为表达载体,构建重组表达质粒pET32(a)-VP1,转化E.coli.Rosseta感受态细胞,获得重组工程菌株。经诱导培养,SDS-PAGE电泳,免疫印迹鉴定表达产物。结果获得了含重组表达质粒pET32(a)-VP1的正相阳性工程菌株,经IPTG诱导能高效表达VP1融合蛋白。结论重组工程菌可表达VP1融合蛋白,对研究EV71发病机制及疫苗研制具有重要意义。 Objective The aim of this study are to construct recombinant expression vector containing VP1 whole gene of enterovirus 71 (EV71)by DNA recombinant technology and to induce expression of VP1 fusion protein in E. coli. Methods The interested gene with total extracted from the serum of patients. These patients were infected by EV71 virus. We inserted it into pET32(a)expression vector to construct recombinant expression vector pET32(a)- VP1. The verified recombinants pET32( a)- VP1 were transformed into E. coli. Rossena to produce bacteria strain with positive recombinants,then the strain were analyzed with SDS - PAGE and immunoblotting to verify the expression product -- VP1 fusion protein. Results The positive bacteria containing the recombinant expressive vector pET28(a) - VP1 were constructed successfully, and high level expression of VP1 fusion protein was performed by inducing with IPTG. Conclusion It played an important role in investigating the pathogenesis of EV71 and developing vaccine in the future that the VP1 fusion protein of the positive strain with recombinant were expressed efficiently in E. coli system.
出处 《临床和实验医学杂志》 2014年第16期1314-1317,共4页 Journal of Clinical and Experimental Medicine
基金 陕西省自然科学基金资助项目 基金编号:2011GM4030
关键词 肠道病毒EV71型 VP1蛋白 表达载体 Enterovirus 71 VP1 protein Expression vector
  • 相关文献

参考文献12

二级参考文献74

  • 1赵顺英,李兴旺,江载芳.关注小儿重症肠道病毒71型感染[J].中华儿科杂志,2008,46(6):401-403. 被引量:232
  • 2杨智宏,朱启镕,李秀珠,王晓红,王建设,胡家瑜,唐伟,崔爱利.2002年上海儿童手足口病病例中肠道病毒71型和柯萨奇病毒A组16型的调查[J].中华儿科杂志,2005,43(9):648-652. 被引量:636
  • 3杨秀惠,何家鑫,严延生,何爱华,沈晓娜,陈前进.一起手足口病暴发的病原学诊断与分析[J].中国人兽共患病学报,2007,23(4):323-326. 被引量:60
  • 4Foo DG, Alonso S, Phoon MC, et al. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res, 2007,125 : 61-68.
  • 5Foo DG, Alonso S, Chow VT, et al. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect, 2007, 9:1299-1306.
  • 6Foo DG, Ang RX, Alonso S, et al. Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots. Clin Microbiol Infect, 2008,14:286-288.
  • 7Wang SY, Lin TL, Chen HY, et al. Early and rapid detection of enterovirus 71 infection by an IgM-capture ELISA. J Virol Methods, 2004 ,119 : 37-43.
  • 8Cello J, Strannegard O, Svennerholm B,et al. A study of the cellular immune response to enleroviruses in humans: identification of erossreaetive T cell epitopes on the structural proteins of enteroviruses. J Gen Virol, 1996, 77 (Pt 9):2097-2108.
  • 9Wei Foo DG, Macary PA, Alonso S, et al. Identification of human CD4(+) T cell epitopes on the VP1 capsid protein of Enterovirus 71. Viral Immunol, 2008, Apr 17. [Epub ahead of print].
  • 10Chang LY. Hsiung CA, Lu CY, et al. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res,2006, 60:466 -471.

共引文献811

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部